Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹50.1 LAccepted-AOC | ₹50.1 L | L1 | Accepted-AOC Accepted with Lowest Quote as L1 |
| 2 | L2₹52.8 LRejected-Finance | ₹52.8 L | L2 | Rejected-Finance L2 Quoted Higher than L1 |
| Sl No | Description | Qty | Unit | Shrikant M Joshi | Canvet Pharma Incorporation Private Limited |
|---|---|---|---|---|---|
| 1.00 | 9 in 1
(Canine Distemper Virus, Canine Adeno Virus – 1, CAV – 2 , Canine Para Influenza Virus, Canine Parvo Virus, LeptospiraCanicola, L.Grippotyphosa, L. Icterohaemorrhagiae and L. Pomona) | 10,000 | 1 ml. | 47,50,000 ₹49,87,500 Lowest | 50,00,000 ₹52,50,000 |
| 2.00 | Disposable Syringe with 23G needle | 10,000 | 2.5 ml. | 22,500 ₹25,200 Lowest | 30,000 ₹33,600 |
Tender Value
Refer Docs
EMD Value
₹1.3 L
Closing Date
2 Jul 2025, 3:00 pmClosed
Director
Dte AHVS SPACES Bldg 4th Floor Patto Panjim Goa
Supply of Combined Canine Vaccines and Syringes
2025_DAHV_23343_1
9-1(21)/VACCINE/2025-26/1279
Open Tender
Drugs and Pharmaceutical Products
Supply
AD DIU TONCA CARANZALEM
Please refer Tender documents.
4 documents required · 4 mandatory
₹3,000
₹1.3 L
2 Mar 2026
13 Jun 2025
3 Jul 2025
13 Jun 2025
2 Jul 2025
13 Jun 2025
9 in 1 (Canine Distemper Virus, Canine Adeno Virus – 1, CAV – 2 , Canine Para Influenza Virus, Canine Parvo Virus, LeptospiraCanicola, L.Grippotyphosa, L. Icterohaemorrhagiae and L. Pomona)
Disposable Syringe with 23G needle
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].